Genomes and Genes
Summary: Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.
Publications332 found, 100 shown here
- Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapyCharles J Ryan
Urologic Oncology Program, University of California, San Francisco, San Francisco, CA 94115, USA
J Clin Oncol 28:1481-8. 2010..This phase I dose-escalation study of abiraterone acetate evaluated safety, pharmacokinetics, and effects on steroidogenesis and prostate-specific antigen (PSA) levels in men with CPRC with or without prior ketoconazole therapy.
- Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysisBenoit Tyl
Robert Ballanger s Hospital, Department of Cardiology, Aulnay sous Bois, France
J Clin Pharmacol 52:893-903. 2012..and supratherapeutic doses (20 mg and 100 mg once daily, respectively), and bilastine 20 mg administered with ketoconazole 400 mg...
- Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazoleH Huang
Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA
Oncogene 26:258-68. 2007..We have found that xenobiotic-mediated induction of CYP3A4 and MDR-1 gene transcription was inhibited by ketoconazole, a commonly used antifungal drug...
- In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in ratsMichiharu Kageyama
Department of Pharmacokinetics, Kyoto Pharmaceutical University, Yamashina ku, Kyoto 607 8414, Japan
Biol Pharm Bull 28:316-22. 2005In this study, the in vivo effects of cyclosporin A (CsA) and ketoconazole (KCZ), which are used as inhibitors of P-glycoprotein (Pgp) and cytochrome P450 (CYP) 3A, respectively, on the pharmacokinetics of rhodamine 123 (Rho123), ..
- Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazoleJenny Y Chien
Department of Drug Disposition, Lilly Research Laboratories, Indianapolis, IN 46285, USA
Drug Metab Dispos 34:1208-19. 2006..A physiologically based PK model was developed to predict the inhibition of CYP3A by ketoconazole (KTZ), using midazolam (MDZ) as the substrate...
- Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell linesHesham M Korashy
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8
Toxicol Sci 97:32-43. 2007..Therefore, we examined here the ability of three structurally different antifungal drugs, ketoconazole (KTZ), itraconazole (ITZ), and fluconazole (FLZ) to induce the CYP1A1, an enzyme known to play an important ..
- Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazoleWendy W J van de Sande
Erasmus MC, University Medical Centre Rotterdam, Department of Medical Microbiology and Infectious Diseases, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Microbes Infect 9:1114-23. 2007..added to the culture medium, MICs were found to be 16-fold elevated in the case of itraconazole and 32-fold for ketoconazole. MICs for amphotericin B, fluconazole and voriconazole were not affected...
- Cytochrome P450 3A4 inhibition by ketoconazole: tackling the problem of ligand cooperativity using molecular dynamics simulations and free-energy calculationsUrban Bren
Institute of Molecular Modeling and Simulation, University of Natural Resources and Life Sciences, Muthgasse 18, AT 1190 Vienna, Austria
J Chem Inf Model 52:1573-82. 2012..was applied to elucidate the physicochemical origin of the observed positive homotropic cooperativity in ketoconazole binding to CYP3A4...
- Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazoleJ A Urbina
Centro de Biologia Celular, Facultad de Ciencias, Universidad Central de Venezuela, Caracas
Mol Biochem Parasitol 30:185-95. 1988Highly purified preparations of plasma membranes from control and ketoconazole-treated (1 microM, 120 h) epimastigotes of Trypanosoma cruzi have been obtained by cell disruption using abrasion with glass beads, differential centrifugation ..
- Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in generalH Boxenbaum
Arishel Inc, North Potomac, Maryland, USA
J Pharm Pharm Sci 2:47-52. 1999..When triazolam is the P450 3A4 substrate and ketoconazole the competitive inhibitor, Ki approximately 1.2 microg/mL in humans...
- Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dogJ G Mouatt
Veterinary Teaching Hospital, University of Queensland, St Lucia
Aust Vet J 80:207-11. 2002To assess the use of concurrent ketoconazole and low dose cyclosporin administration in a group of dogs with clinical evidence of perianal fistulas, and to determine if this combination could be used to manage perianal fistulas effectively...
- Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosisM A Shikanai-Yasuda
Department of Infectious and Parasitic Diseases, School of Medicine, Sao Paulo University, Brazil
Med Mycol 40:411-7. 2002Forty-two patients with active paracoccidioidomycosis were randomized to receive itraconazole (50-100 mg d(-1)), ketoconazole (200-400 mg d(-1)) or sulfadiazine (100-150 mg kg d(-1) up to 6 g d(-1)) for 4-6 months, followed by slow ..
- Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substratesShahrzad Dilmaghanian
Division of Clinical Pharmacology and Toxicology, University of Colorado Health Sciences Center, Denver, Colorado, USA
Chirality 16:79-85. 2004Racemic ketoconazole (KTZ) was the first orally active azole antifungal agent used in clinical practice and has become widely used in the treatment of mucosal fungal infections associated with AIDS immunosuppression and cancer ..
- Efficacy of combined cyclosporine A and ketoconazole treatment of anal furunculosisT O'Neill
Small Animal Hospital, University of Liverpool, Crown Street, Liverpool L7 7EX
J Small Anim Pract 45:238-43. 2004Cyclosporine A and ketoconazole were used as a combined therapy to treat 19 dogs with anal furunculosis. Complete resolution of all lesions was achieved in three to 10 weeks, but recurrences occurred in seven of the 19 dogs (36...
- Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomersAnnika Allqvist
Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology at Karolinska University Hospital, Huddinge, Stockholm, Sweden
Eur J Clin Pharmacol 63:173-9. 2007The antifungal drug ketoconazole (KTZ) is known as an inhibitor of, especially, the CYP3A subfamily, which catalyzes the metabolism of a large variety of drugs...
- Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B studyCharles J Ryan
Urologic Oncology Program, University of California, San Francisco, California 94143, USA
Clin Cancer Res 13:2030-7. 2007Adrenal androgens activate the androgen receptor and stimulate prostate cancer growth. Ketoconazole is used as an inhibitor of adrenal androgen synthesis in men with androgen-independent prostate cancer...
- Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole aloneOliver Sartor
Dana Farber Cancer Institute, Boston, MA, USA
Clin Genitourin Cancer 7:E90-2. 2009b>Ketoconazole is a commonly used secondary hormonal therapy in castration-refractory prostate cancer (CRPC), but disease progression inevitably occurs...
- Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazoleK Amber
Department of Biosciences, Jamia Millia Islamia, New Delhi, India
Phytomedicine 17:921-5. 2010..antifungal effect of Ocimum sanctum essential oil (OSEO) and established azole antimycotics-fluconazole and ketoconazole. To put forward this approach, antifungal activity has been assessed in seventy four fluconazole-sensitive and ..
- Effects of rifampin and ketoconazole on the pharmacokinetics of nilotinib in healthy participantsChiaki Tanaka
Oncology Clinical Pharmacology, Novartis Pharmaceuticals Corporation, 180 Park Ave, Florham Park, NJ 07932, USA
J Clin Pharmacol 51:75-83. 2011..conducted in healthy volunteers prior to and following treatment with a strong inducer (rifampin) or inhibitor (ketoconazole)...
- Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjectsRichat Abbas
Pfizer Inc, Collegeville, PA 19426, USA
J Clin Pharmacol 51:1721-7. 2011..The effect of coadministration of ketoconazole on the pharmacokinetic (PK) profile of bosutinib was evaluated in an open-label, randomized, 2-period, ..
- Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA response and disease progressionDaniel Keizman
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Prostate 72:461-7. 2012..Compounds targeting CYP-17 hydroxylase and lyase, as ketoconazole and abiraterone, block adrenal/intratumoral androgen biosynthesis, and are used as sequential endocrine ..
- A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patientsPaul R Womble
Department of Urology, University of Kansas Hospital, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Urol 186:882-7. 2011..Looking for improvement on these outcomes, we conducted a phase II clinical trial examining the combination of ketoconazole and docetaxel in the neoadjuvant setting before radical prostatectomy.
- Synthesis of novel brassinosteroid biosynthesis inhibitors based on the ketoconazole scaffoldKeimei Oh
Department of Biotechnology, Faculty of Bioresource Sciences, Akita Prefectural University, Nakano, Akita, Japan
Bioorg Med Chem Lett 22:1625-8. 2012..We synthesized novel triazole derivatives, based on the ketoconazole scaffold, that function as inhibitors of BR biosynthesis...
- The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogsLaura L Gray
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA
Vet Dermatol 24:118-25.e27-8. 2013Ciclosporin (CSA) is approved for the treatment of canine atopic dermatitis. Ciclosporin is metabolized by liver cytochrome P450 enzymes, a process inhibited by ketoconazole (KTZ).
- Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxelAvivit Peer
Department of Oncology, Rambam Medical Center, Haifa, Israel
Prostate 74:433-40. 2014..However, in countries where abiraterone has not been approved yet, or for patients who cannot afford it, ketoconazole is used as an alternative CYP 17 inhibitor...
- Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazoleS Shin
College of Pharmacy, Duksung Women s University, Ssangmoondong 419, Dobongku, Seoul, Korea
Lett Appl Microbiol 36:111-5. 2003To evaluate the fungitoxic activity of the essential oil of Agastache rugosa alone and to determine its combination effect with ketoconazole against Blastoschizomyces capitatus.
- Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP)Anshul Gupta
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195 7610, USA
J Pharm Sci 96:3226-35. 2007..The goal of this study was to investigate the interactions of azole antifungal agents, ketoconazole, itraconazole, fluconazole, and voriconazole, with BCRP...
- Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's diseaseLucio Vilar
Division of Endocrinology, Hospital das Clinicas, Federal University of Pernambuco, Recife, Brazil
Pituitary 13:123-9. 2010..the effectiveness of cabergoline (at doses of up 3 mg/week), alone or combined with relatively low doses of ketoconazole (up to 400 mg/day), in 12 patients with CD unsuccessfully treated by transsphenoidal surgery...
- Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal modelH Cohen
Ministry of Health, Beer Sheva Mental Health Center, Anxiety and Stress Research Unit, P O 4600, Beer Sheva, Israel
Eur Neuropsychopharmacol 10:429-35. 2000..b>Ketoconazole (KTCZ), an imidazole derivative, is a potent inhibitor of gonadal and adrenal steroidogenesis...
- HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26AJames V Chithalen
Department of Biochemistry, Queen s University, Kingston, ON, K7L 3N6, Canada
J Lipid Res 43:1133-42. 2002..Both initial and secondary metabolic steps after 4-oxo-all-trans-retinoic acid are ketoconazole-sensitive, suggesting that steps in the production of water-soluble metabolites are cytochrome P450-dependent.
- Ketoconazole increases fingolimod blood levels in a drug interaction via CYP4F2 inhibitionJohn M Kovarik
Novartis Pharma, Building WSJ 210 427, 4002 Basel, Switzerland
J Clin Pharmacol 49:212-8. 2009..In vitro experiments showed that ketoconazole significantly inhibited the oxidative metabolism of fingolimod by human liver microsomes and by recombinant ..
- Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancerMary Ellen Taplin
Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA
Clin Cancer Res 15:7099-105. 2009..was designed to assess responses to blocking multiple steps in androgen synthesis with inhibitors of CYP17A1 (ketoconazole) and type I and II 5alpha-reductases (dutasteride) in patients with castration-resistant prostate cancer (CRPC).
- Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton sppS Shin
College of Pharmacy, Duksung Women s University, Dobongku, Seoul, South Korea
J Appl Microbiol 97:1289-96. 2004To determine the effects of herbal essential oils on Trichophyton spp. growth and to evaluate the effects of Pelargonium graveolens oil and its main components citronellol and geraniol combined with ketoconazole against Trichophyton spp.
- Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's diseaseF Castinetti
Department of Endocrinology, Diabetes, Metabolic Diseases and Nutrition, Hopital de la Timone, Centre Hospitalier Universitaire de Marseille and Faculté de Médecine, Universite de la Mediterranee, 264 rue St Pierre, Cedex 5, 13385 Marseille, France
Eur J Endocrinol 158:91-9. 2008..Adjunctive treatments each have specific drawbacks. Despite its inhibitory effects on steroidogenesis, the antifungal drug ketoconazole was only evaluated in series with few patients and/or short-term follow-up.
- In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafineA K Gupta
Division of Dermatology, Department of Medicine, Sunnybrook and Women s College Health Sciences Center Sunnybrook site and the University of Toronto, Canada
Br J Dermatol 142:758-65. 2000..03-64.0 microg/mL) of three azole drugs, ketoconazole, voriconazole and itraconazole, as well as the allylamine terbinafine, using the agar dilution method...
- Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583)Eric J Small
UCSF Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St, Room A 718, San Francisco, CA 94115, USA
J Clin Oncol 22:1025-33. 2004..Thereafter, adrenal androgen ablation with agents such as ketoconazole (K) is commonly utilized. The therapeutic effect of AAWD alone was compared with simultaneous AAWD and K therapy...
- A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancerWilliam D Figg
Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
J Urol 183:2219-26. 2010This phase I study of high dose ketoconazole and docetaxel was designed against castration resistant prostate cancer to determine the maximum tolerated doses, side effects, and pharmacokinetic interaction of co-administered docetaxel and ..
- Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrumLu Yu
State Key Laboratory for Molecular Virology and Genetic Engineering, Chinese Center for Disease Control and Prevention, Beijing 100176, China
Antimicrob Agents Chemother 51:144-53. 2007Trichophyton rubrum is a pathogenic filamentous fungus of increasing medical concern. Two antifungal agents, ketoconazole (KTC) and amphotericin B (AMB), have specific activity against dermatophytes...
- Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysisRicardo M Santa-Rita
Departmento de Ultra estrutura e Biologia Celular, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, CP 926, 21045 900, Rio de Janeiro, Brazil
J Antimicrob Chemother 55:780-4. 2005Investigation of the antiproliferative synergy of the lysophospholipid analogues (LPAs) edelfosine, ilmofosine and miltefosine with the ergosterol biosynthesis inhibitor ketoconazole against Trypanosoma cruzi.
- High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effectsD L Trump
University of Wisconsin Clinical Cancer Center, Madison
J Clin Oncol 7:1093-8. 1989High-dose ketoconazole (400 mg orally three times a day) and physiologic replacement doses of glucocorticoids (hydrocortisone, 20 mg 8 AM, 10 mg 4 PM, and 8 PM) were administered to 38 patients with advanced prostatic cancer, refractory ..
- A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitisR A Squire
PPD Development, Chelmsford, Essex, UK
J Dermatolog Treat 13:51-60. 2002..Due to its antimycotic activity, ciclopirox olamine is established as an effective treatment for these scalp conditions. Salicylic acid has keratolytic properties and aids in the removal of scales...
- Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activityYing Jan Wang
Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan, Taiwan
J Cell Biochem 87:147-59. 2002..b>Ketoconazole (KT) is a worldwide used oral antifungal agent with a broad spectrum of activity against both superficial and ..
- Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogsAlison J Patricelli
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin Madison, 53762, USA
J Am Vet Med Assoc 220:1009-16. 2002To evaluate efficacy and cost of using cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs.
- The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesisGeorge N Tzanakakis
Department of Histology, School of Medicine, University of Crete, Heraklion, Greece
Int J Gastrointest Cancer 32:23-30. 2002..The purpose of this study was to evaluate the anti-metastatic potential of ketoconazole, a thromboxane synthetase and 5-lipoxygenase inhibitor, on hepatic metastasis from a human pancreatic ..
- In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activityA K Gupta
Division of Dermatology, Department of Medicine, Sunnybrook and Women s College Health Science Center, Sunnybrook Site, and the University of Toronto, Toronto, ON, Canada
Br J Dermatol 149:296-305. 2003....
- Population-based case-control study of oral ketoconazole treatment for birth outcomesZoltán Kazy
Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary
Congenit Anom (Kyoto) 45:5-8. 2005The objective of the study presented here was to check the effect of oral ketoconazole treatment on fetal development...
- Identification and quantitation of cis-ketoconazole impurity by capillary zone electrophoresis-mass spectrometryMaría Castro-Puyana
Department of Analytical Chemistry, Faculty of Chemistry, University of Alcala, Ctra Madrid Barcelona Km 33 600, 28871 Alcala de Henares, Madrid, Spain
J Chromatogr A 1114:170-7. 2006trans-Ketoconazole was identified and quantified as impurity of cis-ketoconazole, an antifungal compound, by capillary zone electrophoresis-electrospray-mass spectrometry (CZE-ESI-MS)...
- Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptorCedric Duret
INSERM U632, Hepatic Physiopathology, 1919 Route de Mende, 34293 Montpellier, France
Mol Pharmacol 70:329-39. 2006..In the current study, we investigated the effect of ketoconazole and other azole-derived drugs, miconazole and fluconazole, on the transcriptional activity of the human GR (hGR)..
- Activated pregnenolone X-receptor is a target for ketoconazole and its analogsHongwei Wang
Albert Einstein Cancer Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA
Clin Cancer Res 13:2488-95. 2007..Because the orphan receptor, pregnenolone X-receptor (PXR), coordinately regulates the expression of paclitaxel metabolizing and transport enzymes, controlling this process could improve therapeutic outcome...
- Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental studyHong Zhang
Department of Dermatology, The First Affiliated Hospital, Jinan University, Guangzhou, P R China
Planta Med 76:53-61. 2010..The study examined the synergism of tetrandrine (TET) on ketoconazole (KCZ) candidacidal activity...
- Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitroDavid J Greenblatt
Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine and Tufts Medical Center, Boston, MA, USA
Xenobiotica 40:713-20. 2010Despite the extensive use of ketoconazole as an index inhibitor of human cytochrome P450 3A (CYP3A) isoforms in vitro, literature reports of the quantitative inhibitory potency of ketoconazole are highly variable...
- Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteersYazdi K Pithavala
Pfizer Oncology, 10555 Science Center Drive, San Diego, CA 92121, USA
Invest New Drugs 30:273-81. 2012..This study evaluated changes in axitinib plasma pharmacokinetic parameters and assessed safety and tolerability in healthy subjects, following axitinib co-administration with the potent CYP3A inhibitor ketoconazole.
- Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndromePeter Kamenicky
Faculte de Medecine Paris Sud, Unité Mixte de Recherche S693, and Institut National de la Santé et de la Recherche Médicale Unité 693, Universite Paris Sud, Le Kremlin Bicêtre F 94276, France
J Clin Endocrinol Metab 96:2796-804. 2011..Mitotane combined with fast-acting steroidogenesis inhibitors might avoid the need for emergency bilateral adrenalectomy in patients with severe hypercortisolism...
- Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: the basis of its anti-inflammatory effectGaku Tsuji
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
J Invest Dermatol 132:59-68. 2012b>Ketoconazole (KCZ) has been shown to exhibit anti-inflammatory effects in addition to its inhibitory effects against fungi; however, the underlying molecular mechanism remains poorly understood...
- Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticlesVinay Kumar Venishetty
Department of Pharmaceutical Sciences, Texas Tech University Health Science Center, 1406 S Coulter, Amarillo, TX 79106, USA
Nanomedicine 9:111-21. 2013..A potential drug-drug interaction exists between docetaxel and ketoconazole because both agents are metabolized hepatically by the cytochrome P-450 system, and ketoconazole can inhibit p-..
- Hydrogel of ketoconazole and PAMAM dendrimers: formulation and antifungal activityKatarzyna Winnicka
Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Białystok, Mickiewicza 2c, 15 222 Białystok, Poland
Molecules 17:4612-24. 2012b>Ketoconazole (KET), an imidazole derivative with well-known antifungal properties, is lipophilic and practically insoluble in water, therefore its clinical use has some practical disadvantages...
- Ketoconazole ion-exchange fiber complex: a novel method to reduce the individual difference of bioavailability in oral administration caused by gastric anacidityChe Xin
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
Pharm Dev Technol 18:1346-54. 2013..This method is based on ion exchange of ion-exchange fibers. Water-insoluble faintly alkaline drug ketoconazole was used as a model drug...
- The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjectsRodger Kempsford
GlaxoSmithKline R and D, Stevenage, Hertfordshire, SG1 2NY, UK
Br J Clin Pharmacol 75:1478-87. 2013To investigate the effects of the cytochrome P450 3A4 (CYP3A4) inhibitor ketoconazole on the pharmacokinetics (PK) and pharmacodynamics of fluticasone furoate (FF) and vilanterol trifenatate (VI).
- Phase II trial assessing granulocyte-macrophage-colony stimulating factor, ketoconazole plus mitoxantrone in metastatic castration-resistant prostate cancer progressing after docetaxel treatmentsRobert J Amato
The University of Texas Health Science Center at Houston, Department of Internal Medicine, Division of Oncology, Houston, Texas 77030, USA
Cancer Invest 31:177-82. 2013..objective response and safety for the combination of granulocyte macrophage-colony stimulating factor (GM-CSF), ketoconazole, and mitoxantrone in castration-resistant prostate cancer (CRPC) patients who previously failed docetaxel-based ..
- Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cellsEva Iniguez
Department of Biological Sciences, Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX, 79968, USA
J Biol Inorg Chem 18:779-90. 2013..search for new metal-based chemotherapeutic agents against leishmaniasis and Chagas disease, six new ruthenium-ketoconazole (KTZ) complexes have been synthesized and characterized, including two octahedral coordination complexes-cis,..
- Rationale for combination ketoconazole/ vitamin D treatment of prostate cancerD M Peehl
Department of Urology, Stanford University School of Medicine, Stanford, California, USA
Urology 58:123-6. 2001..Adjuvant therapy combined with androgen deprivation may slow or prevent progression. Ketoconazole plus calcitriol therapy is an example of 1 such a combination with a mechanistic basis for synergistic activity...
- Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampinT Kerbusch
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam
Clin Pharmacol Ther 70:132-41. 2001..The aim of this study was to investigate modulation of the CYP-mediated metabolism of ifosfamide with ketoconazole, a potent inhibitor of CYP3A4, and rifampin (INN, rifampicin), an inducer of CYP3A4/CYP2B6.
- Steroid synthesis inhibition with ketoconazole and its effect upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humansMichael Deuschle
Central Institute of Mental Health, Mannheim, Germany
Neuropsychopharmacology 28:379-83. 2003..We studied the effect of treatment with 800 mg ketoconazole (3 weeks) upon the concentrations of basal plasma cortisol in the evening, corticosteroid-binding globulin (CBG)..
- Treatment of cutaneous leishmaniasis with ketoconazole creamA Z Momeni
Isfahan University of Medical Sciences, PO Box 81465 1191, Isfahan, Iran
J Dermatolog Treat 14:26-9. 2003..Many drugs have been suggested for the treatment of CL but most of them used intramuscularly or intravenously. Recently, a ketoconazole tablet has been used for the treatment of CL.
- CYP3A5*1/*3 genotype influences the blood concentration of tacrolimus in response to metabolic inhibition by ketoconazoleNirupama Chandel
Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Pharmacogenet Genomics 19:458-63. 2009b>Ketoconazole retards metabolic degradation of tacrolimus through its effect on the cytochrome P-450 enzyme system and allows reduction in treatment costs...
- Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancerMari Nakabayashi
Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
BJU Int 105:1392-6. 2010To assess the efficacy of the androgen-synthesis inhibitor ketoconazole as a secondary hormonal therapy in patients with castration-resistant prostate cancer (CRPC) previously treated with chemotherapy, as persistent androgens appear to ..
- Use of oral ketoconazole to prevent postoperative erections following penile surgeryK C Evans
Urology Service, Madigan Army Medical Center, Tacoma, Washington 98431, USA
Int J Impot Res 16:346-9. 2004Analgesics and topical agents ineffectively inhibit painful erections after penile and urethral surgery. Oral ketoconazole reversibly inhibits testosterone production and has been used empirically at our institution to decrease ..
- Ketoconazole, an antifungal agent, protects against adiposity induced by a cafeteria dietJ Campion
Department of Physiology and Nutrition, University of Navarra, C Irunlarrea, 31008 Pamplona, Spain
Horm Metab Res 36:485-91. 2004b>Ketoconazole, an anti-glucocorticoid agent, is widely used in humans as an antifungal agent. It inhibits ergosterol synthesis and reduces cortisol levels in the treatment of Cushing's Syndrome...
- Anti-Candida effects of estragole in combination with ketoconazole or amphotericin BSeungwon Shin
College of Pharmacy, Duksung Women s University, Seoul, Korea
Phytother Res 18:827-30. 2004The anti-Candida effects of estragole combined with amphotericin B or ketoconazole, commonly used antifungal drugs for treatment of candidasis, were evaluated in this study...
- Microbiological assay of ketoconazole in shampooInara Staub
Programa de Pós Graduação em Ciências Farmacêuticas, UFRGS, Av Ipiranga 2752 Porto Alegre CEP 90610 000, Brasil
Int J Pharm 292:195-9. 2005b>Ketoconazole, an anti-fungal agent, is often incorporated in several pharmaceutical forms and in shampoo formulation it is known to be effective against fungal infection on the scalp...
- Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive modeShuso Takeda
Graduate School of Pharmaceutical Sciences, Kyushu University, 3 1 1 Maidashi, Higashi ku, Fukuoka 812 8582, Japan
Drug Metab Dispos 34:1277-82. 2006..we investigated the effects of P450 inhibitors (cimetidine, sulfaphenazole, erythromycin, nifedipine, and ketoconazole) on the UGT2B7-catalyzed formation of morphine-3-glucuronide (M-3-G) and morphine-6-glucuronide (M-6-G)...
- In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytesMasoomeh Shams-Ghahfarokhi
Department of Mycology, Faculty of Medical Sciences, Tarbiat Modarress University, Tehran 14115 111, Iran
Fitoterapia 77:321-3. 2006..well as 35 strains of various dermatophyte species and compared with the activity of a known antifungal drug, ketoconazole (KTZ)...
- Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancerWei Peng Yong
Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, 5841 S Maryland Ave, MC2115, Chicago, IL 60637, USA
Cancer Chemother Pharmacol 60:811-9. 2007..Hence, this study was designed to evaluate if pharmacokinetic modulation of oral etoposide with ketoconazole could lead to a favorable alteration of etoposide pharmacokinetics, and to assess the feasibility and safety of ..
- Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulationsNoah Scheinfeld
Department of Dermatology, Columbia University, New York, NY 10019, USA
Drugs Today (Barc) 44:369-80. 2008Topical ketoconazole, an imidazole, has been a mainstay of treatment for fungal infections and seborrheic dermatitis...
- NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compoundsJoerg Konter
Institute of Pharmacy, Department of Pharmaceutical Medicinal Chemistry, Friedrich Schiller University Jena, Philosophenweg 14, D 07743 Jena, Germany
Bioorg Med Chem 16:8294-300. 2008Novel hybrid compounds combining the antifungal drug ketoconazole with a diazen-1-ium-1,2-diolate or an organic nitrate moiety and the corresponding NO-donors without ketoconazole were synthesized and their activities against a broad ..
- Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbitsJunjie Zhang
Pharmaceutic and Pharmacology Department, Henan Eye Institute, Henan Key Laboratory of Keratopathy, Zhengzhou, China
J Ocul Pharmacol Ther 24:501-6. 2008The aim of this study was to develop an aqueous ketoconazole (KET) eye drop in order to increase the corneal permeability and improve ocular bioavailability following topical application.
- Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction studyKarthik Venkatakrishnan
Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts 02139, USA
Clin Ther 31:2444-58. 2009..The proteasome inhibitor bortezomib undergoes oxidative biotransformation via multiple cytochrome P450 (CYP) enzymes, with CYP3A4 identified as a partial, yet potentially important, contributor based on in vitro drug metabolism studies...
- The pharmacokinetics of ketoconazole and its effects on the pharmacokinetics of midazolam and fentanyl in dogsB Kukanich
Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA
J Vet Pharmacol Ther 33:42-9. 2010b>Ketoconazole inhibits the Cytochrome P450 3A12 (CYP3A12) metabolizing enzyme as well as the p-glycoprotein efflux pump. The extent and clinical consequence of these effects are poorly understood in dogs...
- Retrospective analysis of the consequences of acid suppressive therapy on ketoconazole efficacy in advanced castration-resistant prostate cancerSidney V Keisner
Texas Tech University Health Sciences Center, Dallas, USA
Ann Pharmacother 44:1538-44. 2010The area under the curve of a single ketoconazole dose has been shown to decrease significantly when administered with acid suppressive therapy...
- Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosinJoachim Troost
Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, Germany
Br J Clin Pharmacol 72:247-56. 2011..However, data on potential drug-drug interactions between tamsulosin and inhibitors of CYP2D6 and 3A4 are limited and information on potential pharmacodynamic consequences of such pharmacokinetic interactions is missing...
- Ketoconazole: a thromboxane synthetase and 5-lipoxygenase inhibitor with antimetastatic activity in B16-F10 melanomaP A Nardone
Department of Internal Medicine, University of Massachusetts Medical School, Worcester
J Surg Res 44:425-9. 1988..The purpose of this study was to determine the antimetastatic potential of ketoconazole, a thromboxane synthetase and 5-lipoxygenase inhibitor...
- Fatal liver failure due to ketoconazole treatment of a girl with Cushing's syndromeE Zollner
Department of Paediatrics, University of Cape Town, South Africa
J Pediatr Endocrinol Metab 14:335-8. 2001A patient is reported who developed fatal liver failure on ketoconazole treatment for Cushing's syndrome...
- Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeastsP Lintu
Department of Dermatology, Turku Allergy Research Unit, MediCity Research Laboratory, University of Turku, Turku, Finland
Allergy 56:512-7. 2001..Two studies have shown the efficacy of ketoconazole in the treatment of this type of AD, in contrast to results of topical treatment...
- Effect of multiple dosing of ketoconazole on pharmacokinetics of midazolam, a cytochrome P-450 3A substrate in beagle dogsMasanori Kuroha
Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, 3 5 8 Saiwai cho, Fuchu, Tokyo 183 0054, Japan
Drug Metab Dispos 30:63-8. 2002To evaluate effects of multiple dosing of ketoconazole (KTZ) on hepatic CYP3A, the pharmacokinetics of intravenous midazolam (MDZ, 0.5 mg/kg) before and during multiple dosing of KTZ were investigated in beagle dogs...
- Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazoleM S Pyun
College of Pharmacy, Duksung Women s University, Seoul 132 714, Republic of Korea
Phytomedicine 13:394-400. 2006..The combined effects of Allium oils with ketoconazole were tested by the checkerboard titer test. Among the tested oils, A. sativum for...
- A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanismJan Faergemann
Sahlgrenska University Hospital, Department of Dermatology, SE 41345 Goteborg, Sweden
Expert Opin Pharmacother 8:1365-71. 2007..SD responds to the use of antifungal medications such as ketoconazole, suggesting that the inflammation could be linked to the Malassezia spp...
- Spectroscopic and kinetic studies on the interaction of ketoconazole and povidone drugs with DDQM Pandeeswaran
Department of Chemistry, Gandhigram Rural University, Gandhigram 624302, India
Spectrochim Acta A Mol Biomol Spectrosc 69:1082-8. 2008The kinetics and mechanism of the interaction between 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and ketoconazole and povidone drugs has been investigated spectroscopically...
- Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, SingaporeLynette S M Ngo
Department of Medical Oncology, National Cancer Centre, Singapore
Ann Acad Med Singapore 36:811-4. 2007..b>Ketoconazole, an antimycotic which affects the synthesis of androgens and other steroids, has shown direct cytotoxic effects ..
- The role of ketoconazole in seborrheic dermatitisMarcel Borgers
Barrier Therapeutics NV, Geel, Belgium
Cutis 80:359-63. 2007Although the prominent broad-spectrum activity of ketoconazole was reported in the early 1980s, its effect against Malassezia species was most pronounced; thus, it was developed for the treatment of various skin infections in which a link ..
- Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumorsPatricia LoRusso
Karmanos Cancer Institute, 4100 John R, 4 HWCRC, Detroit, MI, 48201, USA
Invest New Drugs 26:455-62. 2008..The purpose of this phase 1b, drug-drug interaction study was to investigate the effect of ketoconazole, a strong inhibitor of the cytochrome P450 3A4 isoenzyme, on the pharmacokinetics and tolerability of motesanib ..
- Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemateDalia A Hamdy
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
Chirality 21:704-12. 2009The stereoselective pharmacokinetics of ketoconazole (KTZ) enantiomers were studied in rat after i.v. and oral administration of (+/-)-KTZ. Sprague-Dawley rats were administered racemic KTZ as 10 mg/kg i.v...
- Inhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4alpha interactionYun Ping Lim
Department of Pharmacology, Medical College, National Cheng Kung University, Tainan, Taiwan
Pharmacogenet Genomics 19:11-24. 2009Earlier studies have shown that ketoconazole inhibits CYP3A4 expression through pregnane X receptor (PXR)-mediated transcription and coactivator interaction. The involvement of other nuclear receptors remains to be elucidated...
- Ketoconazole-induced JNK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cellsKo Long Lin
Department of Rehabilitation, Kaohsiung Veterans General Hospital, 813 Kaohsiung, Taiwan
Toxicol In Vitro 23:1268-76. 2009This study examined the effect of ketoconazole on viability, apoptosis, mitogen-activated protein kinases (MAPKs) and Ca(2+) levels in MG63 osteosarcoma cells...
- In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humansPritsana Raungrut
Department of Clinical Pharmacology, Flinders University School of Medicine, Adelaide, Australia
J Pharmacol Exp Ther 334:609-18. 2010..Inhibition screening identified potential interactions with dextropropoxyphene, fluconazole, ketoconazole, and methadone. Inhibitor constant values generated for dextropropoxyphene (3...
- Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in miceGian Wan Soo
Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia
Anticancer Drugs 21:695-703. 2010..interaction with primaquine, which also binds to alpha-1-acid glycoprotein, and its metabolic interaction with ketoconazole, which is a CYP3A4 inhibitor, on its pharmacokinetics and biodistribution...
- Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters?Christopher Reist
VA Long Beach Healthcare System, Long Beach, CA, USA
J Clin Psychopharmacol 32:110-3. 2012..We report here that coadministration of the P-gp and BCRP inhibitor ketoconazole with risperidone may preferentially increase D2 receptor occupancy in the striatum compared to pituitary...
- Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in ratsRagini Vuppugalla
Metabolism and Pharmacokinetics, Department of Pharmaceutical Candidate Optimization, Bristol Mye s Squibb Co, P O Box 4000, Princeton, NJ 08543, USA
Xenobiotica 42:1058-68. 2012..Even for a well-established substrate-inhibitor pair like midazolam-ketoconazole, however, the magnitude of the DDI in rats (e.g. 1...
- Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studiesJames F Sigafoos
Departments of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
Drug Metab Dispos 40:2090-101. 2012..A ketoconazole clinical drug interaction study, along with the human mass balance findings, confirmed that CYP3A4 contributes ..
- The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory painShivani Ruparel
Department of Endodontics, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Mol Pain 8:73. 2012....
- Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25G Van den Mooter
Laboratorium voor Farmacotechnologie en Biofarmacie, Campus Gasthuisberg O N, Herestraat 49, K U B 3000, Leuven, Belgium
Eur J Pharm Sci 12:261-9. 2001The glass forming properties of ketoconazole were investigated using differential scanning calorimetry (DSC), by quench cooling liquid ketoconazole from T(m)+10 to 273.1 K, followed by subsequent heating at 5 K/min to T(m)+10 K...
- Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin BSeungwon Shin
College of Pharmacy, Duksung Women s University, Seoul 132 714, Korea
Arch Pharm Res 26:389-93. 2003..graveolens on the antifungal activity of amphotericin B and ketoconazole were examined using a checkerboard microtiter assay against both Aspergillus fungi...
- Triazole hypersensitivity in Candida albicansNeeraj Chauhan; Fiscal Year: 2009..the ssk1 mutant retains the wild type levels of sensitivity to other antifungals such as miconazole and ketoconazole (imidazoles), amphotericin B, caspofungin, 5-FC, and a variety of other inhibitors such as Congo red, ..
- JAMES ALAN SHAYMAN; Fiscal Year: 2016..include, but are not limited to, azithromycin, fluoxetine, amiodarone, chloroquine, imipramine, and ketoconazole. Ascertaining the significance of this complication has been problematic for clinicians, as well as scientists ..
- Characterization of a Novel Selective Cytochrome P450 3A5 SubstrateMICHAEL DARIN CAMERON; Fiscal Year: 2013..Some drugs such as ketoconazole have been shown to inhibit the activity of individual P450 enzymes;while other drugs such as rifampicin or ..
- AGE-RELATED GASTRIC CHANGES AND DRUG ABSORPTIONAryeh Hurwitz; Fiscal Year: 1993..the second year, studies will begin of gastrointestinal absorption of the anti-infective agents, enoxacin and ketoconazole. The solubility of both drugs is markedly reduced at pH above 5 and their absorption is depressed by ..
- DRUG METABOLISM BY INTESTINAL FLAVIN MONOOXYGENASESROSITA PROTEAU; Fiscal Year: 2001..inhibitory or stimulatory effects of flavonoids on the metabolism of methimazole, cimetidine, and N-deacetyl ketoconazole will be evaluated using cDNA-expressed human FMOs...
- Sridhar Mani; Fiscal Year: 2014..Towards this end, we have identified and characterized two novel PXR antagonists, ketoconazole and coumestrol, that specifically disrupt the function of activated (ligand-bound) PXR...
- YEAST ERGOSTEROL PATHWAY--NEW ANTIFUNGAL TARGET SITESMartin Bard; Fiscal Year: 1999..classes, the polyenes (amphotericin B) target plasma membrane-bound sterols and the new classes of azoles (ketoconazole, fluconazole, and itraconazole) target the cytochrome P450-mediated step, lanosterol C-14 demethylation...
- REDUCED DRUG INTERACTIONS OF AZOLE ANTIFUNGAL DRUGSJoseph Gal; Fiscal Year: 2003The incidence of serious fungal infections has increased considerably in recent decades. The "azoles" ketoconazole and itraconazole are important and widely-used oral antifungal agents, but the use of these drugs is limited by adverse ..
- Evaluation of CYP24 as a Target for Enhancing Vitamin D*Donald Trump; Fiscal Year: 2006..We have shown that ketoconazole, an inhibitor of CYP24, enhances the anti-tumor effects of calcitriol and decreases CYP24 activity in ..
- Chronic Nicotine's Activation of the HPA AxisTheodore Friedman; Fiscal Year: 2005..The use of agents which modify the stress response such as glucocorticoid synthesis inhibitors (ketoconazole, aminoglutethimide or metyrapone) or antagonists (RU-486), CRH antagonists, such as antalarmin, or agents which ..
- GLUCOCORTICOIDS & VITAMIN D: ROLE IN ANTI-TUMOR EFFECTSCandace Johnson; Fiscal Year: 2009..b>Ketoconazole, an inhibitor of CYP24, the enzyme responsible of catabolism of calcitriol, can synergize with calcitriol and ..
- PHARMACOTHERAPY OF CUE INDUCED COCAINE CRAVINGS Berger; Fiscal Year: 2000..The steroid synthesis inhibitor ketoconazole will be used to inhibit cue- induces increases in cortisol (component 1, Cue Reactivity) If medications can be ..
- Targeting Androgen -IGF Interactions in Prostate CancerCharles Ryan; Fiscal Year: 2009..A widely utilized approach to reducing adrenal androgen production is the use of ketoconazole, an inhibitor of adrenal steroid biosynthesis...
- Human Metabolism of Anti-Abuse MedicationsDavid Moody; Fiscal Year: 2005..The proposal funded during the last period (R01 DA 10100-02) tested the hypothesis that the 3A4 inhibitor, ketoconazole, would inhibit the metabolism of LAAM to its more active metabolites, norLAAM and dinorLAAM, and thereby ..
- REGULATION OF ENZYMES IN MEVALONATE SYNTHESISHARRY RUDNEY; Fiscal Year: 1991..We have found that U18666A ketoconazole and progesterone can inhibit the formation of regulatory oxysterols and allow accumulation of precursors of ..
- ENDOGENOUS FUNGAL ENDOPHTHALMITISDan Jones; Fiscal Year: 1980..Intravenous amphotericin B, intravenous amphotericin B methyl ester, and oral ketoconazole reduce the severity of C...
- HAART Regimens in Substance AbusersDavid Greenblatt; Fiscal Year: 2003....
- GARLIC PREPARATIONS AND ANTIRETROVIRAL DRUGSDavid Greenblatt; Fiscal Year: 2004..The work will provide immediately applicable clinical data on garlic interactions with antiretrovirals, as well as mechanistic data identifying the interaction process and its predictability from in vitro models. ..
- ANTIRETROVIRAL THERAPIES AND SUBSTANCE ABUSEDavid Greenblatt; Fiscal Year: 2002..The in vitro model, if validated, has the potential to provide clinically important information on interactions involving HIV treatments and abusable drugs, at relatively low cost and with no human drug exposure. ..
- CYP3A Function in Aging AfricanAmericansDavid Greenblatt; Fiscal Year: 2006..This study should provide important mechanistic information on the role of age, gender, and ethnicity as sources of variability in CYP3A-mediated drug metabolism and response. ..
- MDR1 and Related Proteins during HIV PI ExposureDavid Greenblatt; Fiscal Year: 2005..The findings will be of importance in understanding lipid disorders related to PIs as well as the kinetics of drugs used to treat HIV and related disorders. ..
- Metabolic Consequences of HAART: CYP3A and P-gpDavid Greenblatt; Fiscal Year: 2003..This multidisciplinary proposal provides a clinical and scientific basis to assess the effects of currently available as well as experimental HAART medications on human CYP3A and P-gp. ..
- CHRONIC BENZODIAZEPINES: BEHAVIOR AND NEUROCHEMISTRYDavid Greenblatt; Fiscal Year: 2005....
- Sterol Biosynthesis in Trypanosomatid ParasitesFrederick Buckner; Fiscal Year: 2004..The drugs discovered in this research program will hopefully provide better future treatment for patients with these devastating diseases. ..
- REGULATION OF CYTOCHROME P4503A ACTIVITY IN THE ELDERLYLisa von Moltke; Fiscal Year: 2004....
- Analytical Reconstruction of Feedback Signaling in Aging MenJohannes Veldhuis; Fiscal Year: 2008..The present proposal develops a general biomathematical framework for dissecting otherwise observed pathways that control hormone output in aging, stress and disease. [unreadable] [unreadable] [unreadable]..
- Novel Active Repressor Model of Human LDL-Receptor RegulationJohannes Veldhuis; Fiscal Year: 2008..This would represent a new treatment approach for patients with atherosclerotic disease. [unreadable] [unreadable] [unreadable] [unreadable]..
- Ensemble Disruption of the GnRH-LH-Testosterone AxisJohannes Veldhuis; Fiscal Year: 2007..Expected corollary outcomes are enhanced diagnosis, assessment and management of more subtle pathophysiology of the male gonadal axis in puberty and adulthood. ..
- Mechanistic bases for age-related androgen deficiencyJohannes Veldhuis; Fiscal Year: 2007..Knowing why testosterone falls should help foster new and safer ways to prevent the problem. [unreadable] [unreadable] [unreadable]..
- ACTIONS OF ESTROGEN IN MATURING GRAAFIAN FOLLICLESJohannes Veldhuis; Fiscal Year: 2005..Understanding such fundamental interactions is important to the rational design of alternative strategies to interrupt normal and rescue impaired steroidogenesis in the maturing Graafian follicle and corpus luteum. ..
- THE AGING GH AXIS IN POSTMENOPAUSAL WOMENJohannes Veldhuis; Fiscal Year: 2005..An enhanced knowledge base should aid ultimately in formulating more innovative preventive and interventional strategies to limit hyposomatotropism in older and/or estrogen-deficient humans. ..
- ENSEMBLE MODEL OF STRESS ACTH-ADRENAL AXISJohannes Veldhuis; Fiscal Year: 2005....
- ANESTHETIC RENAL METABOLISM--MECHANISMS AND CONSEQUENCESEvan Kharasch; Fiscal Year: 2002..More broadly, resulting biochemical and clinical insights will be applicable to the numerous other nephrotoxic haloalkenes that are ubiquitous environmental contaminants. ..
- Enhancing the Safety of Research ParticipantsDonald Trump; Fiscal Year: 2003..abstract_text> ..
- TESTOSTERONE EFFECTS ON MUSCLE IN BURN INJURYArny Ferrando; Fiscal Year: 2004..In addition, these studies will investigate the safety and efficacy of inexpensive agents in ameliorating muscle loss after burn injury. ..
- Functional Infrared Imaging Predicts Radiation MucositisEzra Cohen; Fiscal Year: 2008..Such a tool would have wide applicability in this patient population and would have tremendous impact on their treatment. [unreadable] [unreadable] [unreadable]..
- Molecular Targets of Novel Antifungal CompoundsAmeeta Agarwal; Fiscal Year: 2008..This work will provide a starting point in the development of new antifungal therapies. [unreadable] [unreadable] [unreadable]..
- SPECT IMAGING OF DOPAMINE FUNCTION IN DAYTOP SUBJECTSRobert Malison; Fiscal Year: 2001..abstract_text> ..
- Bayesian Tools for PBPK Models in Drug Interaction ResearchLang Li; Fiscal Year: 2009..Hence, a CYP3A specific inhibitor-substrate combination, ketoconazole-midazolam, is chosen as a starting example...
- Chondrocyte S100/Calgranulins and RAGE in OsteoarthritisRobert Terkeltaub; Fiscal Year: 2009..Completion of the work will reveal new potential targets for therapeutic intervention in OA by disconnecting inflammation from deleterious alteration of chondrocyte differentiation and function. ..
- Herb Drug InteractionsGary Henderson; Fiscal Year: 2004..abstract_text> ..
- Structure/Function Studies on FlavoproteinsIrina Sevrioukova; Fiscal Year: 2007..unreadable] [unreadable]..
- Vulnerability to Drug Abuse and Treatment Efficacy: Animal ModelsMarilyn E Carroll; Fiscal Year: 2010..The proposed research will show how enhanced drug-seeking behavior in vulnerable phenotypes can be reduced at the most critical, vulnerable phases of drug abuse through behavioral and pharmacological interventions. ..
- TGF-BETA, CHLORIDE CHANNELS AND APOPTOSIS OF AIRWAY EPITHELIAL CELLSDevendra K Agrawal; Fiscal Year: 2010..Such investigations would provide unique insights to the pathophysiologic process of chronic asthma and the means to prevent or reverse the disease. ..
- Restoration of Muscle Following Hip SurgeryArny A Ferrando; Fiscal Year: 2010..The amelioration of hypercortisolemia after surgery will be accomplished with a common antifungal agent, ketoconazole, in order to investigate the resultant affects on muscle protein breakdown...
- Neurochemistry of Cocaine ReinforcementNICHOLAS GOEDERS; Fiscal Year: 2002..These results will also provide evidence of the role that is played by steroid hormones in shaping the functional activity of the brain. ..
- Enzyme Targets-Sterol Synthesis-Opportunistic PathogensWILLIAM NES; Fiscal Year: 2004..The results from these studies will facilitate the design of therapeutic strategies aimed to provide species-specific discrimination of inhibition in the ergosterol biosynthetic pathway. ..
- MOLECULAR STUDIES OF GENE TARGETED OLIGONUCLEOTIDESCY STEIN; Fiscal Year: 2002..Finally, in Specific Aim 3, we will amplify the delivery of alt-OMPs and chi-OMPs to cells by condensing them with a novel delivery agent, tetra (N-methylpyridyl) porphine. ..
- Genetics of Opioid Dependence in a Hmong (Thai) IsolateRobert Malison; Fiscal Year: 2007..Such studies, we believe, afford significant, perhaps uniquely powerful, advantages for identifying susceptibility loci for OD. [unreadable] [unreadable] [unreadable] [unreadable]..
- Orthogonal Strategies for Specific Knockout ProductionCY STEIN; Fiscal Year: 2005..Finally, in Specific Aim 4, we will evaluate the molecular consequences of the down regulation of bcl-2 and bcl-xL by employing the 12,000 gene-containing Affymetrix oligonucleotide microarray technology. ..
- HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPYE Sherwood Brown; Fiscal Year: 2004..Through this award, the Pl will extend his previous research experience by adding new skills and knowledge which will be used for investigations at the interface of neuroscience and clinical research. ..
- Cocaine, Disulfiram & DBH: A Pharmacomechanistic StudyRobert Malison; Fiscal Year: 2004..abstract_text> ..
- ENVIRONMENTAL INFLUENCES ON COCAINE SELF-ADMINISTRATIONNICHOLAS GOEDERS; Fiscal Year: 2007..The experiments described in this revised application were designed with these stipulations in mind, taking into consideration the recommendations of the reviewers of the previous submission. ..
- Mechanism of Action of G3139CY STEIN; Fiscal Year: 2007..unreadable] [unreadable] [unreadable]..
- Screen for Mycobacterium Tuberculosis (RMI)E White; Fiscal Year: 2005..tuberculosis. 3) To study the effect of these novel inhibitors on the pantothenate pathway in M. smegmatis. 4) To co-crystallize these compounds with pantothenate synthetase to study their mode of binding ..
- Naltrexone for Bipolar Disorder and Alcohol DependenceE Sherwood Brown; Fiscal Year: 2006..Alcohol use is the primary outcome, and alcohol craving is the secondary outcome. Manic and depressive symptom severity and the relationship between changes in alcohol use and changes in mood will be expIored. ..
- Role of CRH in skin physiology and pathologyAndrzej Slominski; Fiscal Year: 2004..g., melanocytes and keratinocytes, and test the role of CRH/CRH-R1 axis in the regulation of human hair growth. ..
- Pharmacogenetics of MethadoneC Devane; Fiscal Year: 2003..This study will form the basis for subsequent studies which should provide a more rational basis for dosing of methadone in pregnant addicts. ..
- Pharmacotherapy for opioid and cocaine dependenceBruce Rounsaville; Fiscal Year: 2005..4. To examine depression as a predictor of response. 5. To examine three month follow-up status after completing the treatment trial for continuation in treatment, abstinence from illicit drugs, and depressive symptoms. ..
- ADVANCED TRAINING IN SPECT/PET NEURORECEPTOR IMAGINGRobert Malison; Fiscal Year: 2003..abstract_text> ..
- PTHRP 1 to 173 IN CHONDROCYTESRobert Terkeltaub; Fiscal Year: 2005..Completion of these studies will indicate not only how PTHrP 1-173 can modulate OA, but also how functional properties of the PTHrP 1-173 C-terminal 140-173 domain can be harnessed to promote cartilage repair. ..
- STRESS AND THE NEUROBIOLOGY OF DRUG AND ALCOHOL DEPENDENICHOLAS GOEDERS; Fiscal Year: 2004..The primary goal of this Training Program is to provide students and young scientists with comprehensive guidance in stress and drug abuse research. ..
- Role for the HPA Axis in Methamphetamine ReinforcementNICHOLAS GOEDERS; Fiscal Year: 2005..abstract_text> ..